Product Details
Zofran ODT (Tablet)
Ondansetron Hydrochloride4 mg
DIN/PIN/NPN
02239372
Manufacturer
Sandoz Canada Inc.
Formulary Listing Date
2000-04-17
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Not a Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A04AA01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02239372 | Zofran ODT (Tablet) | NA | NA |
| 02389983 | Ondissolve ODF (Film) | 3.2720 | 2.5450 |
| 02481723 | Ondansetron ODT (Tablet) | 3.2720 | 2.5450 |
| 02487330 | Mint-Ondansetron ODT (Tablet) | 3.2720 | 2.5450 |
| 02511282 | Auro-Ondansetron ODT (Tablet) | 3.2720 | 2.5450 |
| 02514966 | Mar-Ondansetron ODT Tablet | 3.2720 | 2.5450 |
| 02519232 | Ondansetron ODT (Tablet) | 3.2720 | 2.5450 |
| 02519445 | PMS-Ondansetron ODT Tablet | 3.2720 | 2.5450 |
| 02524279 | Ondansetron ODT (Tablet) | 3.2720 | 2.5450 |
| 02535319 | Accel-Ondansetron ODT (Tablet) | 2.5450 | 2.5450 |
| 02541351 | Jamp Ondansetron ODF | 3.2720 | 2.5450 |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |